At some point, you’ll get a call from someone selling insurance leads. They have volume, real-time delivery, FCA authorisation mentioned somewhere in the pitch, and a cost-per-lead that looks manageable compared with hiring a new member of staff. What the pitch doesn’t cover is who consented to being contacted, under what exact wording, and what happens when a prospect disputes it. For regulated insurance firms, that gap is where the commercial question and the compliance one are the same question.
What options do regulated insurance firms actually have?
The two broad paths are buying leads from a third-party supplier, or generating them through referrals, content, and relationships. Both can produce pipeline. The key difference is who owns the consent trail, the ad wording, and the data-handling arrangements. For a regulated firm, that ownership question goes further than cost-per-lead: complaints follow the trail back to you regardless of who ran the campaign.
Suppliers such as Beyond Leads market themselves as FCA-authorised, delivering high-intent, exclusive leads in real time via email, API, or CRM. Try Compare says it has provided leads to over 50 brokers since 2018. These vendors represent the typical promises you’ll encounter on the market, which is useful context for setting expectations, but the operational questions remain yours to ask: who approved the landing page, what did the consent form say, and what is the refund arrangement if a lead turns out to have invalid consent?
The referral and content path takes longer to establish. iovox’s guidance on insurance lead generation highlights referrals as a core channel alongside email, social presence, and online forms. Openly recommends combining referrals with educational content rather than relying on paid acquisition alone. Neither route produces pipeline quickly, but both give the firm more control over the quality of the prospect relationship from the very start.
When does buying leads make sense for a regulated firm?
Bought leads suit a firm with spare capacity for rapid follow-up, an established CRM and telephony stack, and a product that converts at volume. If you sell a standardised offering, a compliant supplier can accelerate your pipeline faster than referral-building, particularly in a new geography where you have no existing presence. The commercial upside is real, provided the consent paperwork genuinely holds.
The risk is that “compliant” is a vendor assertion, not a verified status. Contact State’s guidance on the rules of insurance lead generation is explicit: lead buyers share culpability for complaints arising from the advert and landing page used to generate the lead. If a prospect complains about how they were approached, the complaint does not stop at the supplier. Reviewing and signing off the exact ad copy and form wording before buying a single lead is the minimum you should do.
If you have the infrastructure to respond within minutes, a genuine volume appetite, and a supplier who can evidence their consent process in writing, bought leads can be a legitimate growth lever. A vendor who won’t provide that documentation in advance is, in effect, asking you to carry regulatory exposure you haven’t priced.
When does building your own pipeline make more sense?
Referral-led and content-led pipeline fits owner-managed insurance firms better when the service is advisory, higher-ticket, or built around ongoing client relationships. The prospect who arrives via a recommendation or has already read your thinking has context about what you do and why. That reduces the time spent on qualification and, crucially, it removes the third-party consent question entirely.
The FCA’s Insurance Conduct of Business Sourcebook (ICOBS) requires regulated firms to act honestly, fairly, and professionally in customers’ best interests throughout the distribution chain. When a client refers a colleague to you, the relationship starts from trust already established, and the first conversation is about fit rather than credibility. A lead sourced through a comparison site or a social ad campaign has no such foundation, and the early conversations carry more weight as a result.
The ICO’s direct marketing guidance sets a high bar for consent: freely given, specific, informed, and unambiguous, with withdrawal as easy as giving it. Building your own pipeline means your firm sets and controls those standards from the outset. If your service depends on sustained client trust, and advisory insurance relationships almost always do, your lead source should reinforce that trust rather than introduce friction at the first point of contact.
What does getting this wrong actually cost?
The ICO can issue fines of up to £17.5 million or four per cent of annual worldwide turnover for serious UK GDPR breaches. For an owner-managed firm, even a moderate fine, combined with complaint-handling costs, remediation time, and reputational damage with existing clients, can be material. A lead list that looks cheap at purchase can become expensive very quickly if the consent records behind it are weak.
The FCA’s financial promotions rules add another layer: communications must be clear, fair, and not misleading, with marketing claims supported by evidence. If a lead supplier uses ad copy that overstates what your product delivers, the FCA’s scrutiny of the customer acquisition process does not stop at the top of the funnel. The CMA’s consumer protection guidance reinforces the point. Misleading claims and unfair commercial practices are the buyer’s problem too, not only the generator’s.
A practical technology dimension compounds the exposure. If a lead supplier stores prospect data, routes it into your CRM, or exchanges it via API, the NCSC’s supply chain security guidance applies to you directly. You remain responsible for access controls, authentication, and supplier assurance over the data path. Contracting out the lead generation work does not contract out your obligations for what happens to the data.
What should you ask before committing to any lead source?
The five questions that separate compliant from risky lead sources are all about provenance, not price. You want to know how consent was obtained and what the exact wording said, who approved the landing page and the advert, whether the lead is exclusive or shared across multiple buyers, what security controls protect the data in transit, and whether the supplier can evidence complaint and opt-out handling.
Contact State’s guidance is explicit that buyers should sign off the ad and landing page wording before a campaign runs. Ask for it in writing before you commit. If the supplier won’t provide it, that is an answer in itself.
Beyond consent, ask what happens when a lead is invalid or the data turns out to be wrong. What is the refund or replacement policy? Who holds the data controller role, and is there a data processing agreement in place? If the supplier uses AI to score or prioritise prospects, ask what data feeds the model and whether any EU data subjects are in scope. If they are, the EU AI Act’s obligations on automated decision-making, and its prohibitions on certain manipulative AI practices, may apply even for a UK-based firm.
Building these questions into a short supplier checklist takes an hour. Discovering later that a supplier’s consent records do not hold up can take considerably longer to fix.
